Soligenix
SNGX
#10972
Rank
C$11.28 M
Marketcap
C$0.52
Share price
4.90%
Change (1 day)
-77.97%
Change (1 year)

Earnings for Soligenix (SNGX)

Earnings in 2026 (TTM): -C$16.13 Million

According to Soligenix's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -C$16.89 Million a decrease over its 2024 earnings that were of -C$13.33 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Soligenix from 1998 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$16.13 Million-4.51%
2025 -C$16.89 Million26.72%
2024 -C$13.33 Million22.96%
2023 -C$10.84 Million-45.74%
2022 -C$19.97 Million11.88%
2021 -C$17.85 Million-32.37%
2020 -C$26.4 Million83.18%
2019 -C$14.41 Million11.57%
2018 -C$12.92 Million19.29%
2017 -C$10.83 Million33%
2016 -C$8.14 Million-19.7%
2015 -C$10.14 Million5.16%
2014 -C$9.64 Million
2010 -C$10.88 Million26.12%
2009 -C$8.63 Million75.1%
2008 -C$4.93 Million-45.38%
2007 -C$9.02 Million-22.84%
2006 -C$11.69 Million66.15%
2005 -C$7.04 Million-16.65%
2004 -C$8.44 Million13.28%
2003 -C$7.46 Million-11.88%
2002 -C$8.46 Million-59.44%
2001 -C$20.85 Million378.18%
2000 -C$4.36 Million-38.53%
1999 -C$7.1 Million-18.43%
1998 -C$8.7 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$37.35 B-224,027.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$9.84 B-59,115.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$10.20 B-61,279.19%๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
-C$25.88 Million 55.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-C$59.53 Million 256.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$2.28 B-13,813.49%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Cleveland BioLabs
CBLI
-C$3.93 Million-76.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-C$0.14 Billion 712.56%๐Ÿ‡บ๐Ÿ‡ธ USA